Meta expected to unveil smart glasses without camera as privacy concerns grow

Meta is expected to unveil camera-free smart glasses, new camera-equipped Meta Ray-Bans, and potentially lighter augmented-reality glasses at its Connect conference, following sales of more than 7 million EssilorLuxottica co-developed smart glasses last year. The product push reinforces Meta's early lead in consumer AI wearables, but privacy scrutiny, a proposed California class action, and concerns that audio recording remains intrusive could limit adoption; analysts also warn that removing cameras may weaken product differentiation and demand.

Analysis

The investable question is whether wearables become a meaningful extension of Meta’s advertising/data moat or remain a subsidized hardware channel. Near term, Connect can support META’s AI-device narrative, but a product mix shift toward lower-functionality, privacy-oriented units would likely be margin-dilutive and does not by itself create a new earnings leg; management disclosure on pricing, attach rates, return rates and EssilorLuxottica retail expansion matters more than launch-day reception. The key 1-3 month catalyst is evidence that unit growth persists without heavy promotional spend or escalating warranty/support costs.

EssilorLuxottica (EL; US OTC: ESLOY) is the cleaner second-order beneficiary if smart eyewear becomes a recurring optical retail category: it captures frames, prescription-lens economics, distribution and service even if Meta’s hardware profitability is deferred. Conversely, SNAP’s high-end AR positioning is vulnerable to a lower-priced consumer wearable gaining developer attention, but it could benefit if privacy scrutiny forces industry-wide on-device processing and clearer consent standards—areas where enterprise/AR use cases may be more defensible than always-on social capture.

The contrarian risk is that privacy mitigation reduces product differentiation faster than it reduces regulatory risk. Audio, cloud processing, disclosure signage and employee access controls remain potential litigation or regulatory vectors; any new enforcement action could force software changes, geographic restrictions, or higher compliance expense across the category. Over 6-18 months, the largest upside for META requires a credible developer ecosystem and an advertising or commerce surface, not merely incremental device volume; absent those, the market should value this as AI capex rather than a platform expansion.

Key Decisions for Investors

• Maintain META as a core AI exposure but do not add solely into the conference: add only if management provides a measurable adoption KPI and indicates that wearables investment remains within previously communicated expense discipline. Falsify on a material upward revision to 2026 expense/capex without a corresponding monetization timeline.
• Watch-list long EL/ESLOY versus META over the next 1-3 months if retail-door expansion, prescription penetration, or replenishment/service economics are disclosed. This expresses adoption with less exposure to Meta’s device R&D and privacy-liability tail; exit if category demand proves promotion-led or optical channel checks show weak sell-through.
• Avoid a directional SNAP trade on the event. Consider a tactical SNAP short only if its upcoming developer/consumer adoption metrics fail to show differentiation while lower-cost competitors demonstrate traction; cover on evidence of enterprise orders, developer uptake, or a strategic hardware partnership.
• Set a privacy-regulation alert rather than buying protection indiscriminately: a formal regulator action, adverse discovery in litigation, or mandated recording indicators would be a category-level de-rating catalyst. At that point, reduce META and EL exposure first; the likely impact is delayed adoption and higher compliance cost rather than an immediate demand collapse.